New pill on the block - ADDYI FDAs approval of flibanserin to treat HSDD in premenopausal women, represents a women’s health landmark, as it’s the first drug to treat FSD.Originally developed as an anti depressant, Flianserin (Addyi) is approved for low sexual desire in premenopausal women.Addyi may boost sex drive in women who have HSDD and are distressed by it.

It appears to modulate neurotransmitters so as to, on balance, increase sexual desireSide effects include low BP, dizziness, nausea, fatigue, sleepiness and fainting if mixed with alcohol.Unlike the rapid effects of medication for ED benefits of Addyi in reducing HSDD are seen only after first 4 weeks of daily treatment at 100mg at bed time.

Addyi is on sale since october 2015 in USA and it will be quite some time (minimum 24 months) before its available in india.Addyi would have done its job if it encouraged women to atleast acknowledge their sexual dysfunction and bring it to the notice of their doctor’s